Nonmelanoma Skin Cancer
From the Journals
CLL, GVHD may raise risk for skin cancer after allo-HCT
The retrospective analysis identifies previously unknown risk factor for skin cancer associated with allogeneic hematopoietic cell transplantation...
Photo Challenge
Growing Painful Nodule on the Lower Lip
A 56-year-old man presented with a firm growing mass on the right lower lip of 1 year’s duration. He described the mass as painful, and it often...
From the Journals
Pembrolizumab extends Merkel cell PFS, OS
Patients with both Merkel cell carcinoma subtypes had significantly better survival with first-line pembrolizumab, compared with historical...
From the Journals
BCL expression intensity key in distinguishing FL lesions
BCL2 expression intensity is the “single most valuable clue” in differentiating primary cutaneous follicular center-cell lymphoma from secondary...
Conference Coverage
Fine-tune staging for better SCC risk stratification
ORLANDO – SCC staging should be used routinely and the Brigham and Women’s Hospital staging system is the current...
Conference Coverage
Increased risk of second cancers in mycosis fungoides
LA JOLLA, CALIF. – Researchers found the risk of second malignancy was highest among MF patients aged 30 to 50 years and patients who had tumor...
Conference Coverage
Cerdulatinib yields ‘encouraging’ results in CTCL, PTCL
LA JOLLA, CALIF. – Some CTCL patients experienced relief from itching after just one pill.
Case Letter
Locally Destructive Metastatic Basal Cell Carcinoma
Risk factors associated with metastatic spread of basal cell carcinoma include larger tumor size, greater depth of invasion, long duration of...
Latest News
IPH4102 on fast track for Sézary syndrome
The designation is based on results from a phase 1 trial of 35 patients.
Conference Coverage
Long-term mogamulizumab appears safe, effective in CTCL
LA JOLLA, CALIF. – Investigators said that prolonged treatment with the drug does not appear to pose an increased safety risk.
Case Reports
Primary Cutaneous Epstein-Barr Virus–Positive Diffuse Large B-Cell Lymphoma: A Rare and Aggressive Cutaneous Lymphoma
Although rare, Epstein-Barr Virus–positive diffuse large B-cell lymphoma is an important consideration when evaluating a patient with a suspected...